✦ LIBER ✦

Chemotherapy with doxorubicin, etoposide and cyclophosphamide (DEC) in ovarian cancer persistent after platinum-based treatment

✍ Scribed by G. Zanetta; S. Lo Monico; A. Gabriele; D. Miceli; C. Mangioni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxol as Second-Line Treatment in Patien

✍ K. Mayerhofer; E. Kucera; H. Zeisler; P. Speiser; A. Reinthaller; P. Sevelda 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Pharmacokinetics of intraperitoneal doxo

✍ Vinay K. Malviya; Gunter Deppe; Guy Boike; John Young 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Role of salvage cytoreductive surgery in

✍ Aya Matsumoto; Toshihiro Higuchi; Shigeo Yura; Masaki Mandai; Masatoshi Kariya; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

High dose-intensity chemotherapy, with a

✍ Ardizzoni, A.; Venturini, M.; Sertoli, M.R.; Penucci, M.C.; Mariani, G.L.; Garro 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 629 KB

Effect of leuprolide acetate on ovarian

✍ Guiping Song, Hui Gao, Zhixiang Yuan 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 263 KB

517 Clinical (WHO) and serum tumor marke

✍ J.B. Vermorken; R.V.H.P. Huijskes; K. Hoekman; C.W. Burger; R.H.M. Verheijen; M. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB